The EGAPP Working Group was established in 2005 to support the development of a systematic process for assessing the available evidence regarding the validity and utility of rapidly emerging genetic tests for clinical practice. This independent, multidisciplinary panel prioritizes and selects tests, reviews CDC-commissioned evidence reports and other contextual factors, highlights critical knowledge gaps, and provides guidance on appropriate use of genetic tests in specific clinical scenarios.
Nominations for EGAPP Working Group membership are accepted on a continuous basis.
What's New
- The next EWG meeting will be held on August 19 and 20, 2013.
- The last EWG meeting was held on May 13 and 14, 2013.
-
The EGAPP Working Group has published a new article entitled “Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies”
(PDF 656KB) in collaboration with Kaiser Permanente Center for Health Research. - The EWG has published a new recommendation on Type 2 Diabetes Risk Prediction
- The EWG has published a new recommendation on EGFR tumor testing in colorectal cancer patients.
EGAPP Recommendations
- Diabetes: Does genomic profiling to assess Type 2 Diabetes risk improve...
- Colorectal Cancer: Can testing of tumor tissue for mutations in EGFR pathway downstream effector genes...
- Cardiovascular Health: Outcomes of Genetic Testing in Adults with a History of Venous Thromboembolism
- Breast Cancer: Can tumor gene expression profiling improve outcomes…
- Cardiovascular Health: Genomic profiling to assess cardiovascular risk to improve cardiovascular health…
- Colorectal Cancer (Lynch syndrome): Genetic testing strategies in newly diagnosed individuals…
- Colorectal Cancer: Can UGT1A1 genotyping reduce morbidity and mortality…
- Depression: Testing for cytochrome P450 polymorphisms in adults…
File Format Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Page last updated: May 20, 2013
Page last reviewed: April 10, 2013
Content Source: OPHG Staff
© 2009 Evaluation of Genomic Applications in Practice and Prevention (EGAPP)
expressed on this web site do not necessarily represent the views of the funding agency, CDC.
Privacy Policy